RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India


RDIF and Morepen Laboratories announce production of the test batch of Sputnik V in India: The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Morepen Laboratories, one of the leading manufacturers of pharmaceutical products in India, today announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in state of Himachal Pradesh (HP).

Comments

Popular posts from this blog

Eurotech has carved its niche to address Networking and Communications requirements.

CLOUD COMPUTING : Nitin Hiranandani, Director, HP India

DCIM gaining momentum with growth of data centers